上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2013年
13期
16-19,20
,共5页
陈玉双%郑玉林%管海英%黄君勤
陳玉雙%鄭玉林%管海英%黃君勤
진옥쌍%정옥림%관해영%황군근
多黏菌素E%给药途径%剂量%多药耐药菌%新品种
多黏菌素E%給藥途徑%劑量%多藥耐藥菌%新品種
다점균소E%급약도경%제량%다약내약균%신품충
polymyxin E%route of administration%dosage%multidrug resistance bacteria%new preparations
目的:对多黏菌素E注射制剂的相关信息以及临床应用进行综述。方法:参考近年来国内外文献,对三种多黏菌素E注射制剂的基本信息、耐药性和不良反应等进行详尽的整理和讨论,对产品的临床应用进行分类和评价。结果:三种多黏菌素E注射制剂在化学结构、给药途径、给药剂量等方面都存在差异,临床医生在使用的时候尤为需要关注。除静脉注射给药外,多黏菌素E注射制剂尚有雾化吸入、鞘内或脑室内给药以及膀胱灌注等多种给药途径的应用。结论:随着多药耐药菌的出现,多黏菌素E重新获得了青春。但是,该品种仍需进一步的深入研究,同时也需要开发适应临床需求的新品种。
目的:對多黏菌素E註射製劑的相關信息以及臨床應用進行綜述。方法:參攷近年來國內外文獻,對三種多黏菌素E註射製劑的基本信息、耐藥性和不良反應等進行詳儘的整理和討論,對產品的臨床應用進行分類和評價。結果:三種多黏菌素E註射製劑在化學結構、給藥途徑、給藥劑量等方麵都存在差異,臨床醫生在使用的時候尤為需要關註。除靜脈註射給藥外,多黏菌素E註射製劑尚有霧化吸入、鞘內或腦室內給藥以及膀胱灌註等多種給藥途徑的應用。結論:隨著多藥耐藥菌的齣現,多黏菌素E重新穫得瞭青春。但是,該品種仍需進一步的深入研究,同時也需要開髮適應臨床需求的新品種。
목적:대다점균소E주사제제적상관신식이급림상응용진행종술。방법:삼고근년래국내외문헌,대삼충다점균소E주사제제적기본신식、내약성화불량반응등진행상진적정리화토론,대산품적림상응용진행분류화평개。결과:삼충다점균소E주사제제재화학결구、급약도경、급약제량등방면도존재차이,림상의생재사용적시후우위수요관주。제정맥주사급약외,다점균소E주사제제상유무화흡입、초내혹뇌실내급약이급방광관주등다충급약도경적응용。결론:수착다약내약균적출현,다점균소E중신획득료청춘。단시,해품충잉수진일보적심입연구,동시야수요개발괄응림상수구적신품충。
Objective: To review the studies on injectable preparations and clinical application of polymyxin E. Methods:Basic information about drug resistance, adverse reactions and clinical application of three injectable preparations of polymyxin E was classified and reviewed based on recent published literatures. Results: Physicians need to focus on the differences of chemical structure, route of administration and dosage in the use of three injectable preparations of polymyxin E. In addition to intravenous administration, the routes for administration of injectable preparations of polymyxin E including inhalation, intrathecal or intraventricular administration and intravesical irrigation are common. Conclusion:With the emergence of multidrug resistant bacteria, polymyxin E rejuvenated. Further studies on the new drug and the development of new preparations adapted to clinical needs are required.